ArticleAdvances in therapy2026

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of HZBio1 in Chinese Healthy Subjects: A Randomized Phase 1a Study.

Hongzhong Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.